Your browser doesn't support javascript.
loading
Combined treatment with a ß3 -adrenergic receptor agonist and a muscarinic receptor antagonist inhibits detrusor overactivity induced by cold stress in spontaneously hypertensive rats.
Imamura, Tetsuya; Ogawa, Teruyuki; Minagawa, Tomonori; Nagai, Takashi; Suzuki, Toshiro; Saito, Tetsuichi; Yokoyama, Hitoshi; Nakazawa, Masaki; Ishizuka, Osamu.
Afiliación
  • Imamura T; Department of Urology, Shinshu University School of Medicine, Matsumoto, Japan.
  • Ogawa T; Department of Urology, Shinshu University School of Medicine, Matsumoto, Japan.
  • Minagawa T; Department of Urology, Shinshu University School of Medicine, Matsumoto, Japan.
  • Nagai T; Department of Urology, Shinshu University School of Medicine, Matsumoto, Japan.
  • Suzuki T; Department of Urology, Shinshu University School of Medicine, Matsumoto, Japan.
  • Saito T; Department of Urology, Shinshu University School of Medicine, Matsumoto, Japan.
  • Yokoyama H; Department of Urology, Shinshu University School of Medicine, Matsumoto, Japan.
  • Nakazawa M; Department of Urology, Shinshu University School of Medicine, Matsumoto, Japan.
  • Ishizuka O; Department of Urology, Shinshu University School of Medicine, Matsumoto, Japan.
Neurourol Urodyn ; 36(4): 1026-1033, 2017 04.
Article en En | MEDLINE | ID: mdl-27367573
ABSTRACT

AIMS:

This study determined if combined treatment with the muscarinic receptor (MR) antagonist solifenacin and the ß3 -adrenergic receptor (AR) agonist mirabegron could inhibit detrusor overactivity induced by cold stress in spontaneously hypertensive rats (SHRs).

METHODS:

Thirty-two female 10-week-old SHRs were fed an 8% NaCl-supplemented diet for 4 weeks. Cystometric measurements of the unanesthetized, unrestricted rats were performed at room temperature (RT, 27 ± 2°C) for 20 min. The rats were then intravenously administered vehicle, 0.1 mg/kg solifenacin alone, 0.1 mg/kg mirabegron alone, or the combination of 0.1 mg/kg mirabegron and 0.1 mg/kg solifenacin (n = 8 each group). Five minutes later, the treated rats were exposed to low temperature (LT, 4 ± 2°C) for 40 min. Finally, the rats were returned to RT. After the cystometric investigations, the ß3 -ARs and M3 -MRs expressed within the urinary bladders were analyzed.

RESULTS:

Just after transfer from RT to LT, vehicle-, solifenacin-, and mirabegron-treated SHRs exhibited detrusor overactivity that significantly decreased voiding interval and bladder capacity. However, treatment with the combination of solifenacin and mirabegron partially inhibited the cold stress-induced detrusor overactivity patterns. The decreases of voiding interval and bladder capacity in the combination-treated rats were significantly inhibited compared to other groups. Within the urinary bladders, there were no differences between expression levels of M3 -MR and ß3 -AR mRNA. The tissue distribution of M3 -MRs was similar to that of the ß3 -ARs.

CONCLUSIONS:

This study suggested that the combination of solifenacin and mirabegron act synergistically to inhibit the cold stress-induced detrusor overactivity in SHRs. Neurourol. Urodynam. 361026-1033, 2017. © 2016 The Authors. Neurourology and Urodynamics Published by Wiley Periodicals, Inc.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Asunto principal: Tiazoles / Vejiga Urinaria / Antagonistas Muscarínicos / Vejiga Urinaria Hiperactiva / Agonistas de Receptores Adrenérgicos beta 3 / Succinato de Solifenacina / Acetanilidas Tipo de estudio: Etiology_studies Límite: Animals Idioma: En Revista: Neurourol Urodyn Año: 2017 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Asunto principal: Tiazoles / Vejiga Urinaria / Antagonistas Muscarínicos / Vejiga Urinaria Hiperactiva / Agonistas de Receptores Adrenérgicos beta 3 / Succinato de Solifenacina / Acetanilidas Tipo de estudio: Etiology_studies Límite: Animals Idioma: En Revista: Neurourol Urodyn Año: 2017 Tipo del documento: Article País de afiliación: Japón